A carregar...
How we treat endocrine complications of immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) are antibodies that target certain immune checkpoints (ICs), such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed death 1 (PD-1) or its ligand (PD-L1), and have emerged as a powerful new tool for oncologists. As these immune checkpoints are cru...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7807832/ https://ncbi.nlm.nih.gov/pubmed/33399077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2020.100011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|